SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 92.13 |
| Enterprise Value ($M) | 136.20 |
| Book Value ($M) | -45.47 |
| Book Value / Share | -0.98 |
| Price / Book | -2.03 |
| NCAV ($M) | -82.84 |
| NCAV / Share | -1.78 |
| Price / NCAV | -1.11 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.00 |
| Return on Assets (ROA) | n/a |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.54 |
| Current Ratio | 0.54 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 88.24 |
| Assets | 125.61 |
| Liabilities | 171.08 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Polar Asset Management Partners Inc. | 0.00 | -100.00 | |
| 13G/A | Glazer Capital, Llc | 0.00 | -100.00 | |
| 13G/A | Cowen And Company, Llc | 0.00 | -100.00 | |
| 13G/A | Vivaldi Asset Management, LLC | 0.00 | -100.00 | |
| 13G/A | Wolverine Asset Management Llc | 0.00 | -100.00 | |
| 13G | Mizuho Financial Group Inc | 7.40 | ||
| 13G/A | Taconic Capital Advisors LP | 0.00 | -100.00 | |
| 13G/A | Periscope Capital Inc. | 3.70 | -75.84 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 101 | 4,429 | 2.28 | |
| 4,537 | 12,516 | 36.25 | |
| 4,339 | 15,543 | 27.92 | |
| 2,449 | 13,375 | 18.31 | |
| 2,614 | 7,520 | 34.76 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CRON – Cronos Group Inc. | CRSP – CRISPR Therapeutics AG |
| CRVS – Corvus Pharmaceuticals, Inc. | CVAC – CureVac N.V. |
| EOLS – Evolus, Inc. |
Financial data and stock pages provided by
Fintel.io